InvestorsHub Logo
icon url

lasers

07/20/13 3:26 PM

#4008 RE: AG25 #4006

OTC MMs manipulation goes on as long as the equity remains on the OTC. With increasing technical successful Clinical Trials the PPS rises as shares float is reduced by DD Longs accumulating and new buyers take Long Term positions. Punit arranged for Merck-Inovio Partnership and is likely to do the same with Big Pharma for OncoSec. In addition Inovio has ties with USA Military, Bill-Melinda Gates, and others. Taking a position now with OncoSec has the very high potential of OOM PPS increase and Nasdaq listing based solely on science/medical strength.